• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Jack Ansell, MD, Discusses the STABLE Study

Article

The STABLE study compared patients who took weekly tests compared with those who tested less regularly, and found that those who tested weekly had better results than those who did not.

The STABLE study was done to show how warfarin testing worked in a “real world” setting, according to Jack Ansell, MD, lead study investigator and professor of Medicine at Hofstra-North Shore/LIJ School of Medicine. The study compared patients who took weekly tests compared with those who tested less regularly, and found that those who tested weekly had better results than those who did not. In fact, Dr Ansell said, the results for patients testing weekly had better average time in therapeutic range (TTR) than found in most clinical trials. Read the article here.

Related Videos
Imran Khan, MD, PhD, Johnson & Johnson
Fabiola, Molina, MD, MHS | Image Credit: Yale School of Medicine
James Robinson, PhD, MPH, University of California, Berkeley
Patrick Vermersch, MD, PhD
dr daniel ontaneda
Shauna Downs, PhD, MS | Image Credit: Rutgers School of Public Health
Sudipto Mukherjee, MD, PhD, MPH, hematology and medical oncology, Cleveland Clinic
James Robinson, PhD, MPH, University of California, Berkeley
Douglas K. Marks, MD | Image credit: NYU Langone Health
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.